Endogena Therapeutics � Endogena Hematopoietic Recovery

Endogena Therapeutics, founded by Matthias Steger MD PhD, is a clinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs that have deteriorated due to aging and genetic diseases. Hematopoietic recovery is when your body starts making blood cells again after something has stopped it from doing so, like chemotherapy or a bone marrow transplant. This includes making all types of blood cells – red blood cells (that carry oxygen), white blood cells (that fight infection), and platelets (that help with clotting). Endogena is working on the development of an endogenous molecule to facillitate hematopoietic recovery.